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Purpose: To evaluate the performance of lesion volumetry in hepatic CT as a function of various
imaging acquisition parameters.
Methods: An anthropomorphic abdominal phantom with removable liver inserts was designed for
this study. Two liver inserts, each containing 19 synthetic lesions with varying diameter (6–40 mm),
shape, contrast (10–65 HU), and both homogenous and mixed-density were designed to have background and lesion CT values corresponding to arterial and portal-venous phase imaging, respectively.
The two phantoms were scanned using two commercial CT scanners (GE 750 HD and Siemens
Biograph mCT) across a set of imaging protocols (four slice thicknesses, three effective mAs, two
convolution kernels, two pitches). Two repeated scans were collected for each imaging protocol.
All scans were analyzed using a matched-filter estimator for volume estimation, resulting in 6080
volume measurements across all of the synthetic lesions in the two liver phantoms. A subset of portal
venous phase scans was also analyzed using a semi-automatic segmentation algorithm, resulting
in about 900 additional volume measurements. Lesions associated with large measurement error
(quantified by root mean square error) for most imaging protocols were considered not measurable
by the volume estimation tools and excluded for the statistical analyses. Imaging protocols were
grouped into distinct imaging conditions based on ANOVA analysis of factors for repeatability
testing. Statistical analyses, including overall linearity analysis, grouped bias analysis with standard
deviation evaluation, and repeatability analysis, were performed to assess the accuracy and precision
of the liver lesion volume biomarker.
Results: Lesions with lower contrast and size ≤10 mm were associated with higher measurement
error and were excluded from further analysis. Lesion size, contrast, imaging slice thickness, dose,
and scanner were found to be factors substantially influencing volume estimation. Twenty-four
distinct repeatable imaging conditions were determined as protocols for each scanner with a fixed
slice thickness and dose. For the matched-filter estimation approach, strong linearity was observed
for all imaging data for lesions ≥20 mm. For the Siemens scanner with 50 mAs effective dose at
0.6 mm slice thickness, grouped bias was about −10%. For all other repeatable imaging conditions
with both scanners, grouped biases were low (−3%–3%). There was a trend of increasing standard
deviation with decreasing dose. For each fixed dose, the standard deviations were similar among the
three larger slice thicknesses (1.25, 2.5, 5 mm for GE, 1.5, 3, 5 mm for Siemens). Repeatability
coefficients ranged from about 8% to 75% and showed similar trend to grouped standard deviation.
For the segmentation approach, the results led to similar conclusions for both lesion characteristic
factors and imaging factors but with increasing magnitude in all the error metrics assessed.
Conclusions: Results showed that liver lesion volumetry was strongly dependent on lesion size,
contrast, acquisition dose, and their interactions. The overall performances were similar for images
reconstructed with larger slice thicknesses, clinically used pitches, kernels, and doses. Conditions
that yielded repeatable measurements were identified and they agreed with the Quantitative Imaging
Biomarker Alliance’s (QIBA) profile requirements in general. The authors’ findings also suggest
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potential refinements to these guidelines for the tumor volume biomarker, especially for soft-tissue lesions. C 2016 American Association of Physicists in Medicine. [http://dx.doi.org/10.1118/1.4967776]
Key words: quantitative imaging biomarker, liver lesion volumetry, computed tomography, phantom
study

1. INTRODUCTION
Quantitative imaging biomarkers (QIB) correlate with clinical
outcomes and can be used to improve patient care.1 More
focus has been placed on standardization and validation of
QIB through the collaboration of research, industry, and
clinical practice in groups such as the Quantitative Imaging
Biomarker Alliance (QIBA) of the Radiological Society of
North America and the Quantitative Imaging Network (QIN)
of the National Cancer Institute. These organizations seek to
streamline the incorporation and evaluation of QIB in clinical
trials, ultimately improving personalized precision medicine.
The size of a lesion is a useful biomarker for performing
diagnosis, determining tumor progression, and monitoring
response to treatment.2–4 The most commonly used standard
for characterization of lesion size is the Response Evaluation
Criteria In Solid Tumors (RECIST), which requires a 1D
measurement (diameter) of the tumor.5 In 2002, an initial
study found that evaluating treatment response by volumetric
measurement of liver lesions led to different results than
evaluating response using 1D or 2D measurement.6 Later, an
update to RECIST called for more validation, standardization,
and wide-spread availability of volumetric methods before the
adoption of these methods for routine use. Since then, there
have been studies of lesions in phantoms, in the lung, and in
the gastrointestinal tract that have demonstrated that volume
better discriminates changes in lesion size.7–10 For the liver,
a 2012 study by Chalian et al. concluded that measurement
of volumetric attenuation was reproducible in a study of 208
patients, and that it might be a better method of assessing
changes of tumors in response to therapy.11 However, factors
contributing to variability in measuring the volume remained
to be tested.
The uncertainties of the volume measurement process must
be understood before QIB can be fully utilized. Estimation
error depends on a number of factors including acquisition
and reconstruction parameters, lesion characteristics, and
estimation methods.12–14 Imaging of in vivo lesions can only
be performed for a limited range of acquisition factors due
to CT radiation dose concerns for the patients. Zhao et al.
studied the effects of slice thickness and reconstruction
algorithm on tumor measurements from repeat CT scans,
including the volume for lung, liver, and lymph node diseases
in patients.15,16 The use of phantoms allows for a wider
range of factors to be systematically explored. Li et al.
investigated many of these factors (lesion size, shape; scan
exposure, slice thickness) using an anthropomorphic lung
phantom and applied statistical analyses to the volume of
the nodules.17 However, the estimation of liver lesion volume
differs from the estimation of lung nodule volume due to
much lower lesion-to-background contrast and higher noise
Medical Physics, Vol. 43, No. 12, December 2016

levels. Furthermore, liver lesion contrast varies depending
on the timing of the image acquisition with respect to the
intravenous contrast agent injection (arterial phase ∼35 s
after injection, portal-venous phase ∼75 s after injection).
Investigation of volumetric estimation uncertainties for liver
lesions may provide new insight into the design of studies
examining volumetry of other types of soft tissue lesions and
soft tissue lesions in general.
In this work, we investigated the influence of numerous
factors in CT volumetry of liver lesions through a wellcontrolled phantom study. We applied statistical analyses to
over 6000 measurements of lesion volume to determine the
interaction of various imaging factors and the reliability of
the QIB estimation. The phantom design, imaging protocol,
volume estimators, and statistical methods are described in
Sec. 2. In Sec. 3, the results are presented, followed by a
discussion in Sec. 4, and conclusion in Sec. 5.
2. MATERIALS AND METHODS
2.A. Phantom design

An anthropomorphic abdominal phantom with a removable
liver insert was designed by the research team and custom
manufactured by QRM (Moehrendorf, Germany). Two inserts
containing 19 lesions each were made to simulate arterial and
portal-venous phase imaging of the liver. For the arterial phase,
the liver parenchyma was nominally uniform at 80 HU, with
CT values ranging between 60 and 120 HU for the various
synthetic liver lesions. For the portal-venous phase, the CT
value for the liver parenchyma was 110 HU, and the lesion CT
values ranged between 45 and 100 HU. Table I contains a list
of the synthetic lesion properties of the inserts. Eight lesion
sizes (6, 8, 10, 20, 23, 30, 34, 40 mm diameter) and three
shapes (spherical, ellipsoidal, and lobulated), both solid and
mixed density, were included in the liver inserts. The lesion-tobackground contrast (absolute value of HU difference between
lesion and surrounding parenchyma) ranged from 10 to 40 HU
for the arterial phase and 10–65 HU for the portal-venous
phase, where contrast is defined as the absolute difference
between the background and the lesion. A previous study has
shown that a minimum of 10 HU is required to observe the
lesion.18 Figure 1 shows the schematic of the phantom. The
reference standard volume for the lesion was provided by
QRM and was measured prior to final insertion with the liver
inserts.
2.B. Imaging protocols

Imaging protocols utilized in this study are given in
Table II. The phantom was imaged at the Columbia University
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T I. A table of lesion characteristics including nominal lesion density and contrast values for the arterial and
portal venous phase liver inserts at 120 kVp. The nominal radiodensity of liver parenchyma is 80 HU for the
arterial phase and 110 HU for the portal venous phase insert at 120 kVp. Lesions 5–6 and 11–12 refer to mixed
density objects with specified outer/inner properties.
Lesion index

Lesion density (HU)

Contrast (HU)

Arterial

Venous

Diameter (mm)

Shape

Arterial

Venous

Arterial

Venous

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19

20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38

34
34
30
30
30/20
30/20
23
23
20
20
20/10
20/10
40
10
10
8
8
6
6

Lobulated
Lobulated
Ellipsoid
Ellipsoid
Spherical/spherical
Spherical/spherical
Lobulated
Lobulated
Ellipsoid
Ellipsoid
Spherical/spherical
Spherical/spherical
Ellipsoid
Spherical
Spherical
Spherical
Spherical
Spherical
Spherical

60
120
60
120
100/45
90/120
60
120
60
120
100/45
90/120
90
60
90
60
90
60
90

45
75
45
75
90/45
100/60
45
75
45
75
90/45
100/60
100
75
90
75
90
75
90

20
40
20
40
20
10
20
40
20
40
20
10
10
20
10
20
10
20
10

65
35
65
35
20
10
65
35
65
35
20
10
10
35
20
35
20
35
20

Medical Center with two 64-slice multi-detector helical CT
scanners: GE 750HD (GE Healthcare, Chicago, IL, US)
and Siemens Biograph mCT (Siemens Healthcare, Erlangen,
Germany). The data were acquired at 120 kVp and at
three dose levels of approximately 3.8, 7.6, and 19 mGy
corresponding to 50, 100, and 250 effective tube current time
product (mAs), respectively. Effective mAs is defined as (total
mAs)/pitch for the scan. There are small differences between
the acquired pitch and associated slice thicknesses between
the two CT systems as the available setting of these two
imaging parameters is different for these two CT scanners.
For the GE system, we acquired pitch factors of 1.375 and
0.983; for the Siemens system we acquired pitch factors
of 1.35 and 1.0. The mAs was adjusted for each pitch to
reach the three pre-set effective mAs. CT acquisitions for
the Siemens image data acquired at a pitch of 1.0 were
collected for only a single dose of 250 effective mAs. The

GE image data were reconstructed at slice thicknesses of
5.0, 2.5, 1.25, and 0.625 mm and the Siemens data were
reconstructed at 5.0, 3.0, 1.5, and 0.6 mm. Filtered backprojection (FBP) reconstructions were used with two different
kernels from each vendor’s scanner: GE, Standard and Soft
and for Siemens, correspondingly, B30f and B20f. For each
liver insert (arterial, portal-venous), data from two repeated
scans were collected. Figure 2 shows four example images
corresponding to plane A-A and B-B from Fig. 1 for both
the arterial and the portal venous phase with lesion indexes
labeled.
In total, we collected 320 image series (i.e., GE: 48 imaging
protocols ×2 repeats ×2 phantoms; Siemens: 32 imaging
protocols ×2 repeats ×2 phantoms) and 34.4 GB image data.
All of the acquired image data are ready to be submitted
to the quantitative imaging data warehouse (QIDW), the
RSNA/QIBA designated data warehouse.

F. 1. Layout of the anthropomorphic abdominal phantom and liver inserts with fixed built-in lesions. The arterial and portal venous phase liver inserts had the
same lesion layout.
Medical Physics, Vol. 43, No. 12, December 2016
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T II. CT imaging protocols for the anthropomorphic liver phantom. Two repeated scans were acquired for each imaging acquisition condition.
Acquisition parameters

Reconstruction parameters

Scanner

kVp

Eff. mAs

Pitch

Collimation

Slice thickness

Overlap

Recon algorithm

Convolution kernel

GE 750HD

120

50
100
250

1.375
0.983

64 × 0.625

0%

FBP

Standard
Soft

Siemens mCT

120

50
100
250

1.35
1.0a

64 × 0.6
(32 × 0.6 detector width)

5
2.5
1.25
0.625
5
3.0
1.5
0.6

0%

FBP

B30f
B20f

a

Only one effective mAs (250) was acquired for pitch 1.0.

2.C. Volume estimation

Two noncommercial volume estimation tools were used.
The first was a model-based matched-filter (MF) volume
estimator.19 It is unsupervised (i.e., no human corrections
were applied) and assumes prior knowledge of the general
location (a seed point) and the shape for each lesion. For

mixed density lesions, volume measurements were made for
the entire object. More details on the matched-filter method
can be found in the Appendix. The second algorithm is
based on a marker-controlled watershed segmentation (SEG)
approach developed for segmentation of hypo-intense liver
lesions.13 It required manual selection of a region-of-interest
inside the lesion on one image to initiate the segmentation.

F. 2. Example CT slices of the abdominal phantom containing either the arterial [(a) and (b)] or portal venous [(c) and (d)] phase liver insert (250 effective
mAs, slice thickness 2.5 mm, GE 750HD). Note that some small lesions in (b) are not visible at this window level.
Medical Physics, Vol. 43, No. 12, December 2016
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The algorithm then automatically found lesion boundaries on
all image series containing the 3D lesion. For the segmentation
approach, a radiologist also reviewed every segmentation and
made modifications using a noncommercial editing tool when
necessary.
The matched-filter estimator was applied to all 320 image
series, resulting in 6080 volume measurements (320 × 38 lesions). The segmentation estimator was applied on a subset
of data: portal-venous insert lesions, 250 mAs with GE
and 250 mAs with Siemens at pitch 1.0, resulting in 912
measurements.

Grouped bias with standard deviation was reported for each
repeatable imaging condition. Repeatability was evaluated as
repeatability coefficient for each repeatable imaging condition,
with lower value indicating better repeatability.
For a repeatable imaging condition, let yi j k be the volume
measurement for each lesion i = 1,2,...n, each combination
of minor parameters within the repeatable imaging condition
j = 1,2,...m, and each repeated measurement k = 1,2. Let x i
be the reference standard volume. The mean measurement for
the ith lesion in log domain is then
1 
ln yi j k
µi =
2m j,k

2.D. Statistical analysis methods

and the error compared to the reference standard is

2.D.1. Analyses on matched-filter results

Prior to analyses, all data were log-transformed (natural
log) to reduce the heteroscedastic nature that was observed
in our volumetric measurements (variance of the measurements increased substantially with larger lesions without
this transformation). We applied N-way ANOVA with twoway interaction for factor analysis on all measurements,
using lesion size, lesion contrast, effective mAs (dose), slice
thickness, convolution kernel, and scanner as factors. We used
type II sums of squares for ANOVA analysis. Lesion shape
was not included since it was highly correlated with lesion
size (small lesions are all spherical, see Table I). For slice
thickness, 0.6 and 0.625 mm, 1.25 and 1.5 mm, and 2.5 and
3 mm were treated as the same category, respectively. For
a convolution kernel, standard and B30f and soft and B20f
were treaded as the same category, respectively. Based on the
ANOVA results, statistically significant imaging parameters
were considered major parameters. The others were referred
to as minor parameters. Measurements were then pooled for
root mean square error (RMSE) evaluation if they were from
imaging protocols with the same major parameters, where the
error was defined as the volume error (difference between
the volume measurement and the reference standard). Lesions
that were associated with high RMSE were visually inspected
to determine if they were not measurable or likely to be
disqualified in practice for the estimation task. Those lesions
were then excluded for the rest of the analyses.
Same ANOVA analysis was applied again on the measurements of the remaining data. Since two ANOVA analyses were
applied on an overlapping dataset, p-value was set to 0.025
according to Bonferroni correction. Significant factors were
identified and ranked according to eta-squared, which was
calculated as the ratio of the between-group sum of squares
to the total sum of squares.17 Distinct repeatable imaging
conditions were also determined based on the ANOVA results.
Imaging protocols that only differed in minor parameters were
grouped to define a repeatable imaging condition.
Statistical analyses were done based on the metrology
recommendations outlined by the QIBA metrology working
group, which included the analysis of linearity, bias with
standard deviation, and repeatability.20–22 Overall linearity
was assessed by linear regression. Regression slope and
intercept with 95% confidence interval (CI) were reported.
Medical Physics, Vol. 43, No. 12, December 2016

ei j k = ln yi j k − ln x i .
Grouped bias for the repeatable imaging condition was
calculated as
1 
B=
ei j k ,
2nm i, j,k
and standard deviation as


2
1
ei j k − B .
σe =
2nm − 1 i, k, j
The repeatability coefficient (RC) was defined as 2.77 σ w ,
where the within-subject variance σ 2w was calculated as the
mean over all lesions of the variance over all combinations of
minor parameters and repeated measurements,
2
1 * 1 
.
ln yi j k − µi +/ .
n i 2m − 1 k, j
,
All the results in log units were converted to and reported in
percentage in the base unit of measurement.17 More details for
each performance metric used as part of this analysis can be
found in previous work.17,20
σ 2w =

2.D.2. Analysis on segmentation results

The same metrics described above for the matched-filter
results were also used to evaluate the segmentation results.

3. RESULTS
3.A. MF results
3.A.1. Determine lesions to exclude and imaging
protocols to pool

Applying N-way ANOVA with two-way interaction (six
factors: dose, kernel, slice thickness, scanner, size, and
contrast) to all MF volume measurements, we identified the
following statistically significant factors: size, size × slice
thickness, size × dose, size × contrast, dose, slice thickness,
(p < 0.025, interacting factors indicated by ×). Based on those
results, further analysis was conducted across dose and slice
thickness, whereas kernel and scanner were pooled together.
For each of those imaging conditions, RMSEs were evaluated
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F. 3. RMSEs for all lesions across mAs (each row) and slice thickness (each column). Each dot represents the lesion with corresponding size and contrast
(overlapped dots are slightly shifted) with color reflecting the RMSE magnitude. Lesions ≤10 mm are shown within the dotted-box in the first plot.

for each of the 38 lesions. Figure 3 summarizes the RMSE
results. Clearly, the lesions ≤10 mm (lesions 14–19, 33–38)
were associated with large errors for most of the imaging
protocols. For these lesions, there were 1920 measurements,
and among those, 338 measurements were on the limits of
the MF search range (see the Appendix). Therefore, we
considered these lesions as not reliably measurable for our
MF algorithm. Visual inspection of the images also confirmed
the difficulty in detecting these lesions or identifying the
boundary of the lesions (Fig. 4). These small (≤10 mm) lesions
were all excluded, although the 10 mm lesion with +35 HU
contrast (index 33) yielded low RMSE for one or two imaging
conditions with 250 effective mAs. For the rest of the large
lesions (≥20 mm), only 30 out of 4160 were on the limits
of the MF search range, which were mostly associated with

the lowest dose and the thinnest slice thickness protocols and
involved small or low contrast lesions. For the purpose of
keeping data more balanced, those cases were not excluded.
Applying the same ANOVA analysis on large lesions, slice
thickness, size × dose, size, size × contrast, size × slice thickness, dose × slice thickness, contrast × dose, slice thickness
× scanner, contrast × scanner, dose, and dose × scanner were
found statistically significant. Eta-squared was calculated for
each factor and scaled so that summation of the adjusted
eta-squared was 100%. The adjusted eta-squared for all the
significant factors and the others combined is shown in Fig. 5.
Slice thickness turned out to be the most dominant factor
since some low contrast lesions had large errors with thin
slice thickness. Finally, 24 distinct imaging conditions were
defined for repeatability testing based imaging protocols with

F. 4. Center slice images from example lesions. Lesions 34, 36, and 18
were ≤10 mm and were excluded as described in Sec. 3.A.1. Lesions 28 and
8 were ≥20 mm and were included, but degraded image quality is noticeable
over reduced dose. The example images are from a GE dataset with 1.25 mm
slice thickness and standard reconstruction kernel.

F. 5. Adjusted eta-squared in percentage for all significant factors and the
others combined for the MF volume estimator.

Medical Physics, Vol. 43, No. 12, December 2016
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F. 6. Scatter plot for the reference standard and measurements (in log domain) for (a) GE and (b) Siemens scanner. Blue/red lines in plot (a)/(b) correspond to
the regression lines for GE and Siemens data, respectively, which aligned well with the diagonal (green-dotted) line. Note that a small random offset was added
to the x-coordinate of each point (reference standard) to avoid over-plotting of the data points.

the same slice thickness, dose, and scanner (4 slice thicknesses
× 3 doses × 2 scanners).
3.A.2. Linearity

Scatter plot of the data (measurements versus reference
standard) and the linear regression lines is given in Fig. 6. Note
that separate analyses were conducted for each scanner since
the interaction between scanner and slice thickness, contrast,
and dose was found to be of significant factors by ANOVA.
For GE, the slope and intercept of the regression line were
0.989 (95% CI [0.984, 0.994]) and 0.099 (95% CI [0.055
0.144]), respectively. For Siemens, the slope and intercept
of the regression line were 0.995 (95% CI [0.989, 1.002])
and 0.038 (95% CI [−0.020 0.097]), respectively. For both
scanners, the regression lines were close to the diagonal,
indicating good linear relationship between measurements
and reference standard, and on average results in low biased
estimates.
3.A.3. Grouped bias analysis

Table III summarized biases and standard deviations for
all large lesions with each repeatable imaging condition. We
observed overall low biases (within −3.04% to 2.30%) except

for the Siemens, 0.6 mm, 50 eff. mAs imaging condition, for
which bias was about −10%. There was a trend of increasing
standard deviation with decreasing dose. For each fixed dose,
the standard deviations were similar among the three larger
slice thicknesses (1.25, 2.5, 5 mm for GE, 1.5, 3, 5 mm for
Siemens). Standard deviations were highest for the smallest
slice thickness and decreasing dose, indicating a possible
benefit of larger slice thickness for this low-contrast task to
reduce noise through data averaging.
3.A.4. Repeatability

Similar to bias and variance analysis, we evaluated the
repeatability coefficients for each repeatable imaging condition. Results are shown in Fig. 7. The performances between
the two scanners were comparable for imaging conditions
associated with lower noise (higher mAs and larger slice
thicknesses). Slice thickness influenced the repeatability but
there was no clear pattern. With 250 mAs, repeatability
coefficients for all slice thicknesses were similar for GE
and repeatability coefficients for slice thicknesses larger or
equal to 1.5 mm were similar for Siemens. As far as dose
was concerned, there was a general decreasing trend in
the repeatability coefficient (i.e., better repeatability) with
increasing dose.

T III. Biases ± standard deviations (in %) for measurements imaged with the three doses coupled with the
four slice thicknesses for each scanner.
GE

250 eff. mAs
100 eff. mAs
50 eff. mAs

Siemens

0.625 (mm)

1.25 (mm)

2.5 (mm)

5 (mm)

0.6 (mm)

1.5 (mm)

3 (mm)

5 (mm)

−0.42
±4.57
−2.39
±11.80
−2.09
±16.56

−0.53
±4.42
−0.67
±5.85
−1.84
±13.55

0.50
±4.27
0.51
±5.42
0.39
±9.96

0.88
±6.08
2.13
±6.82
2.30
±9.80

−1.16
±8.22
−3.04
±14.82
−9.67
±25.91

−0.11
±3.74
0.13
±6.77
−0.34
±7.28

0.51
±3.73
1.07
6.09
0.47
±9.21

1.39
±4.03
1.81
±6.53
1.47
±10.74

Medical Physics, Vol. 43, No. 12, December 2016
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F. 7. Plots of repeatability coefficients (in %). The 95% CI are indicated
by error bars.

3.B. SEG results

In this section, measurements obtained by the semiautomatic segmentation algorithm are analyzed.
The segmentation algorithm (without human correction)
failed to segment most small lesions (≤10 mm). When that

6615

happened, the radiologist manually segmented the lesion. The
segmentation also failed for a number of thin slice thickness
scans and among those, there were two cases where the
radiologist (M.Z.) could not detect any lesion. The radiologist
also reported that when he measured the lesions from images
acquired on the Siemens scanner at first, he had little or
no knowledge about the lesion characteristics, whereas he
was much more aware of the lesion characteristics when
segmenting the lesion from the GE images at a later time.
In particular, for the mixed-density lesions (lesion 24, 25, 30,
31), he was more certain that those lesions had a low contrast
ring outside of the inner sphere. Therefore, we observed very
inconsistent measurements for those lesions across the two
scanners. Especially for lesion 25 and 31, where the outer
shell of the lesions had a contrast of 10 HU, the radiologist’s
performance was substantially improved for the GE scan data
segmented at a later time. As such, the mixed-density lesions
were excluded from analysis.
Linearity of segmentation results is shown in Fig. 8. In
Figs. 8(a) and 8(b), all measurements for homogenous lesions
were included. Again, small lesions were associated with
large errors. Figures 8(c) and 8(d) show the results with
large homogenous lesions only. The slopes were significantly

F. 8. Scatter plot for the reference standard and measurements (in log domain) for [(a) and (b)] all segmentation results [(c) and (d)] homogenous large lesions
for GE and Siemens, respectively. Dotted and solid lines correspond to the diagonal line, regression lines for GE or Siemens data, respectively.
Medical Physics, Vol. 43, No. 12, December 2016
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T IV. Biases ± standard deviations (in %) for measurements of large homogenous lesions across the four
slice thicknesses for each scanner.
Scanner
Slice thickness (mm)
Biases
±stdev

GE
0.625
12.49
±12.01

1.25
4.88
±6.29

Siemens
2.5
1.61
±7.85

5
9.86
±9.97

0.6
2.08
±15.40

1.5
−2.71
±7.80

3
−0.43
±8.05

5
11.34
±6.34

selected such that the matched-filter method could serve as
a performance bound whereas the semi-automatic approach
with a radiologist correction would better represent expected
results in clinical practice. In this section, we will discuss
the main findings of this study and their connection to QIBA’s
current CT Tumor Volume Change Profile on measuring tumor
volume and volume change.23
For both estimation approaches, we found that the performance of lesion volume estimation was strongly dependent on
lesion size, lesion-to-background contrast, acquisition dose,
and their interactions. Due to the high noise levels associated
with abdominal scans, liver lesions that were less or equal to
10 mm in diameter were found to be too difficult to estimate,
even at clinically realistic dose levels. For lesions of size
20 mm or larger, the performance depended on the lesion
contrast, size, and CT dose. Higher contrast, larger size, and
higher dose yielded more accurate and precise measurements.
The semi-automated segmentation approach also failed often
for small lesions and thin slice scans. The radiologist reported
that the scans from lower doses were too noisy to work
with, meaning that only the 250 effective mAs dataset was
measured for the semi-automated approach. As such, lower
dose degraded the estimation performance for segmentation
approach too.
The main claim of QIBA’s CT Tumor Volume Change
Profile states that “a measured increase in mass volume of
30% or more indicates that a true increase has occurred with
95% confidence,” which was based on the clinical performance
target. For that performance target to be achieved, the tumor
is required to be measurable and the longest in-plane diameter
is between 10 and 100 mm. The lesion contrast has not been
explicitly addressed in the profile, but lesions with very low

different from 1 and the intercepts significantly different from
0 (p < 0.05) for the segmentation-based estimates.
For homogenous large lesions, we ended up with 430
measurements. We evaluated the grouped biases and standard
deviations, and the repeatability coefficients for each scanner
with each slice thickness. The results are reported in Tables IV
and V. For bias and standard deviation, the middle range slice
thicknesses (1.25, 1.5, 2.5, 3 mm) yielded relatively better
results than the others. Unlike for the matched-filter approach,
the pattern for repeatability coefficients with different slice
thicknesses was different from what was observed for the
grouped standard deviation. For instance, for Siemens with a
0.6 mm slice thickness reconstruction, the standard deviation
was the highest among all slice thicknesses, but it also
yielded the best repeatability. A close inspection of the
measurements for each lesion (Fig. 9) showed that there
was large between-subject variability (i.e., biases for some
lesions were substantially different than others). Thus, the
grouped standard deviation was large. However, withinsubject variability was small so that the measurements were
quite repeatable. Recall that according to linearity analysis, the
slope was not particularly close to 1 so it was not surprising
to see large between-subject variability.

4. DISCUSSION
In this study, we examined the volumetry of liver lesions
with CT, using images of an anthropomorphic liver phantom
acquired with various imaging protocols. Volume measurements for lesions of multiple sizes and contrasts were extracted
using two estimation tools. The two estimation tools were

T V. Repeatability coefficients (in %) for measurements of large homogenous lesions across the four slice
thicknesses for each scanner: (a) GE, (b) Siemens.
(a)
Scanner
Slice thickness (mm)
Repeatability coefficient (%)
95% CI

GE
0.625
12.25
[10.35,15.03]

1.25
7.58
[6.42,17.42]

2.5
20.74
[17.42,25.65]

5
20.83
[17.49,25.75]

(b)
Scanner
Slice thickness (mm)
Repeatability coefficient (%)
95% CI

Medical Physics, Vol. 43, No. 12, December 2016

Siemens
0.6
7.47
[5.86,10.30]

1.5
11.00
[8.60,15.27]

3
13.13
[10.25,18.29]

5
9.16
[7.17,12.66]

6617

Li et al.: Volumetry of low-contrast liver lesions with CT

6617

F. 9. Boxplot for differences between measurement and reference standard
(in log) for each lesion. Data are from Siemens scans with 0.6 mm slice
reconstruction and 250 effective mAs.

contrast probably would fail the qualitative “measurability”
criteria in the QIBA Profile so the Profile would likely not
be applicable to these lesions. Our results suggested that
it is likely important to consider at least the lesion’s size
and contrast in determining which lesions are appropriately
measurable within the QIBA Profile. Lesion contrast was
found to be much less important for lung nodules because
the contrast between a lung nodule and the background lung
parenchyma is typically much larger than that found between
a liver lesion and the liver background. The importance of
both size and contrast could potentially be used to make the
QIBA definition of “measurable” more systematic to apply.
In addition to lesion characteristics, imaging parameters
more or less influence the image quality and impact the performance of the volume estimation. However, the “best” imaging
conditions are task-based and are not easy to standardize,
since changes in each parameter to gain certain benefits
often lead to some sacrifice in other aspects. For instance,
increasing dose reduces image noise but poses additional
patient risks, increasing slice thickness reduces image noise
but leads to lower spatial resolution along the z-axis, changes
in reconstruction kernel are associated with trade-off between
image noise and spatial resolution, to name a few. To achieve
the clinical performance target in QIBA’s claim, the Profile
also has requirements on the imaging protocols in addition to
lesion characteristics. They included but are not limit to the
following: (1) the standard deviation for the central region
of a uniform 20 cm cylindrical water phantom should be
no greater than 18 HU; (2) the reconstruction kernel shall
be consistent (for scans of different time points to measure
change); and (3) slice thickness shall be set to less than or
equal to 1.5 mm. We evaluated the pixel standard deviation
and the results are shown in Fig. 10. We found that, in general,
the imaging conditions resulting in poor repeatability (large
repeatability coefficient) (Fig. 7) corresponded to those with
pixel noise higher than 18 HU. Regarding the reconstruction
kernel, no impact on measurements was found for either
volume estimation method, although different kernels led to
quite different noise levels. In comparison to the standard/B30f
kernel (GE/Siemens), the small noise reduction provided by
the soft/B20f kernel (GE/Siemens) is accompanied by a small
sacrifice in spatial resolution. These two competing effects
appear to basically offset each other resulting in no appreciable
change in the overall performance of the volume estimation.
Medical Physics, Vol. 43, No. 12, December 2016

F. 10. Noise measurements of a water phantom for imaging protocols
used in this study (pitch 1.0 for GE and 0.98 for Siemens were almost the
same). H, M, and L on x-axis correspond to eff. mAs of 250, 100, and 50,
respectively. The diameter of the water phantom is 21.6 cm and a region of
interest of 400 mm2 was used for standard deviation evaluation. The dashed
line corresponds to 18 HU.

In this work, we chose the standard (B30f) and soft (B20f)
kernels as they are commonly used in clinical practice for
abdominal studies. Our results suggested that the standard
(B30f) and soft (B20f) kernel could be used interchangeably.
Finally, for slice thickness, our data suggest a less restrictive
requirement than that of the QIBA’s Profile, which could be
appropriate when sizing liver lesions. In particular, at 250
effective mAs, slice thicknesses of 0.625, 1.25, and 2.5 mm
for GE and slice thicknesses of 1.5, 3, and 5 mm for Siemens
yielded similar performances in terms of overall bias, variance,
and repeatability for the matched-filter estimation approach.
For segmentation results, slice thickness of 2.5 mm for GE and
3 mm for Siemens also yielded similar or better performance
compared to those from smaller slice thicknesses scans. With
5 mm slice thickness, the repeatability coefficients for both
scanners were below 30%, which is the clinical target of
QIBA’s CT Tumor Volume Change Profile. One reason that
large slice thicknesses produced relatively small error in this
study is that the lesions qualified for measuring were 20 mm
or larger, which is typical for liver lesions in clinical practice.
In addition, images with larger slice thickness produced less
noisy scans, which was found to be especially important for
low-contrast lesions in the liver. In current clinical practice,
protocols for abdominal CT scanning are typically thicker than
1.5 mm due to the high noise presented and the clinical interest
in relatively large lesions in the liver. While this might change
in the future with better imaging techniques, at the current
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T VI. Matched-filter results parallel to Table V: repeatability coefficients (in %) for measurements of large
homogenous lesions imaged with the two scanners coupled with the four slice thicknesses.
Scanner
Slice thickness (mm)
Repeatability coefficient

GE
0.625
7.68

1.25
5.50

stage, to perform lesion volume estimation in the abdomen
area with reasonable dose, the QIBA’s CT Tumor Volume
Change Profile might need to relax the requirement on the
slice thickness.
Finally, in this study, two estimation approaches were
applied, one based on a matched-filter approach that was
designed as a low-bias estimator and thus produced a
bound on performance, and a segmentation-based method
which better represented the performance expected in clinical
practice. Results from matched-filter were indeed much
better compared to segmentation results in terms of linearity, accuracy, and precision. For example, repeatability
coefficients for the same dataset were smaller for matchedfilter (Table VI versus Table V). The purpose here is not
to compare the estimators but to investigate the source
of variations and build a framework for protocol standardization and algorithm performance evaluation. More
informed estimators such as the matched-filter method can
be used to identify and test sources of variation from the
imaging systems and measurement tools. Also, they could
be used as part of an initial systematic test to determine
if certain lesions are measurable since those deemed not
measurable are expected to have a substantial degradation
in volume estimation performance. Our segmentation results,
on the other hand, may more closely approximate volume
estimation tools currently available for use and also can
incorporate an important additional source of variation coming
from the clinician directly interacting with the segmentation
tool.
There are limitations to our study. First, there was a size gap
between 10 and 20 mm. We included lesions that were most
clinically relevant in the liver (size 20 mm and larger) and the
sub-centimeter lesions to investigate the limit of lesion size
that could be reliably estimated. Our previous studies in the
lung indicated that 10 mm lesions could be reliably estimated,
unfortunately, it was not the case for low contrast liver
lesions in this study. Supplemental studies with lesions within
10–20 mm size range should be performed. Second, while the
x-ray spectrum is a key factor that impacts lesion contrast,
which may lead to different estimation performance, kVp was
fixed in our study. The 120 kVp setting was selected because it
was thought to be most appropriate based on the physical size
of the liver phantom and the fact that the reference lesion and
parenchyma CT values given by the phantom manufacturer
were based on 120 kVp. Clinically, different kVps are selected
based on patient sizes. Since the effect of patient size is not
within the scope of our study, we did not vary kVp. Adding fat
rings to allow investigation of kVp is a potential addition to a
future study. Third, FBP reconstruction was the only method
evaluated in this study. As there is a strong need to investigate
Medical Physics, Vol. 43, No. 12, December 2016

Siemens
2.5
4.82

5
5.73

0.6
4.99

1.5
4.84

3
6.27

5
5.31

the impact iterative reconstruction algorithm’s on estimation,
we are now conducting a study focusing on how iterative
reconstruction impacts liver-lesion volume estimation. Fourth,
only one radiologist did the manual correction to the semiautomatic segmentation. For that one reader, the reading order
was not randomized. Thus the statistical power of the results
for that approach was reduced. We plan to perform more
analyses once we collect more segmentation results (better
controlled readings, more radiologists).
5. CONCLUSION
In this work, we evaluate the performance of liver lesion
volumetry in hepatic CT with various imaging parameters.
Our results show that liver lesion volumetry is strongly
dependent on lesion size and contrast, acquisition dose, and
their interactions. The overall performances were similar for
images reconstructed with larger slice thicknesses, clinically
used pitches, kernels, and doses. Conditions that yielded
repeatable measurements were identified and they agreed with
the QIBA’s Profile requirement in general. Our findings also
suggest potential refinements to these guidelines for the tumor
volume biomarker, in particular the guidelines may be tailoring
to different types of lesions, especially for soft-tissue lesions.
However, any such tailored refinements need to be weighed
against the simplicity of a single approach for all types of
lesions.
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T VII. Template variables for volume estimation. Initial estimates are determined prior to matching: centroid
from manual estimation, background and lesion density from regions on the edge and center (respectively) of the
volume of interest. The half-pixel offsets in x, y are created by repositioning the object prior to CT simulation,
and the quarter-pixel offsets in z are created by decimating a high-resolution template.
Variable
Centroid pixel offset
Background density
Lesion density
Lesion size

Values

Step size

Initial estimate ± 3 pixels
Initial estimate ± 30 HU
Initial estimate ± 20 HU
80%–120% of ground truth diameter mm

0.5 pixels in x, y; 0.25 in z
1 HU
1 HU
1% of ground truth diameter mm

APPENDIX: MATCHED-FILTER
ESTIMATOR IMPLEMENTATION
The volumes of the lesions were estimated using a modification of the matched-filter-based method of Gavrielides
et al.19 For each data acquisition, and for each target lesion, the
method minimizes the difference between the lesion volume
of interest and a collection of simulated 3D templates. These
templates were generated by a model of the CT imaging
system mapping from the object shape to the sinogram, and
by filtered back-projection mapping from the sinogram to the
image.24 The templates vary in centroid-position, density, and
size, as shown in Table VII.
For each target lesion, there are over 5.6 × 108 (13 x
location × 13 y location × 25 z location × 61 background
density × 41 lesion density × 41 diameter) possible configurations of the template (for mixed density lesions, there
is an additional density and size variable leading to over
2.3 × 1010 configurations; note that sizes for both inner and
entire objects are estimated but only the measurements for the
entire objects are used in the analysis), and determining the
optimal template from an exhaustive search is computationally
prohibitive. Instead, we use a coordinate descent method
known as Powell’s conjugate direction.25 The objective
function is minimized for each variable in sequence, followed
by a minimization in the conjugate direction based on the
net change. This process is iterated until convergence to a
minimizing template. To account for noise in the image—
which can lead to local minima—we begin the matchedfiltering of each volume of interest with ten random initial
conditions, run Powell’s method on each, and then choose the
final template with the minimal cost function. Depending on
the properties of the target data, we find that Powell’s method
requires between 2 and 7 iterations to converge. In total, at
most 9.8 × 104 configurations are examined for each volume
of interest using the iterative coordinate descent, several orders
of magnitude lower than the exhaustive search.
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